Estadístiques de Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Visites totals
| views | |
|---|---|
| Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs | 101 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 2 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| llaneras-joh-effe.pdf(legacy) | 363 |
| llaneras-joh-effe.pdf | 27 |
Vistes principals per país
| views | |
|---|---|
| United States | 67 |
| China | 8 |
| Spain | 7 |
| Germany | 6 |
| Saudi Arabia | 4 |
| Ecuador | 2 |
| Austria | 1 |
| Belgium | 1 |
| Ireland | 1 |
| Iran | 1 |
| Malaysia | 1 |
| Ukraine | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 14 |
| Boardman | 9 |
| Ashburn | 8 |
| Shenzhen | 8 |
| Mountain View | 7 |
| Menlo Park | 5 |
| Jeddah | 4 |
| Fairfield | 3 |
| San Diego | 3 |
| Alcalá De Henares | 2 |
| Barcelona | 2 |
| Parsdorf | 2 |
| Quito | 2 |
| Redwood City | 2 |
| San Mateo | 2 |
| Ann Arbor | 1 |
| Dallas | 1 |
| Los Vargas | 1 |
| Madrid | 1 |
| Petaling Jaya | 1 |
| Vienna | 1 |